Maternal tobacco smoking and lung epithelium-specific proteins in amniotic fluid

Pediatric Research

Volumn 50, Issue 4, 2001, Pages 487-494

  Hermans, C ^a   Libotte, V ^a   Robin, M ^a   Clippe, A ^a   Wattiez, R ^a   Falmagne, P ^a   Langhendries, J P ^a   Bernard, A ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; CLARA CELL PROTEIN; CYSTATIN C; RETINOL BINDING PROTEIN; SECRETORY PROTEIN; SURFACTANT ASSOCIATED PROTEIN; SURFACTANT PROTEIN A; TRANSFERRIN;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; GEL ELECTROPHORESIS; HUMAN; LUNG ALVEOLUS EPITHELIUM; MAJOR CLINICAL STUDY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; REGRESSION ANALYSIS; SMOKING; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

EID: 0034802818     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200110000-00011     Document Type: Article

References (50)

1. Active and passive tobacco exposure: A serious pediatric health problem
2. Effects of mammal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants
3. Children's passive and prenatal exposure to cigarette smoke
4. Respiratory function among preterm infants whose mothers smoked during pregnancy
5. The effect of maternal smoking during pregnancy on early infant lung function
6. Lung function, pre- and post-natal smoke exposure, and wheezing in the first year of life
7. In utero exposure to cigarette smoking influences lung function at birth
8. Transplacental transfer of environmental genotoxins: Polycyclic aromatic hydrocarbon-albumin in non-smoking women, and the effect of maternal GSTM1 genotype
9. Maternal smoking induces cotinine levels and genotoxicity in second trimester amniotic fluid
10. Lung injury: Cell-specific bioactivation/deactivation of circulating pneumotoxins
11. Lung epithelium-specific proteins. Characteristics and potential applications as markers
12. Clara cell protein in human amniotic fluid: A potential marker of fetal lung growth
13. Surfactant proteins A SP-A and D SP-D: Levels in human amniotic fluid and localization in the fetal membranes
14. Appearance of paoproteins of pulmonary surfactant in human amniotic fluid
15. Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity
16. Surfactant protein A is decreased in a rat model of congenital diaphragmatic hernia
17. The concentration of the 35-kDa surfactant apoprotein in amniotic fluid from normal and diabetic pregnancies
18. Serum and BAL Clara cell 10 kDa protein CC10 levels and CC10-positive bronchiolar cells are decreased in smokers
19. Serum Clara cell protein: An indicator of bronchial cell dysfunction caused by tobacco smoking
20. Clara cells and Clara cell 10 kD protein CC10
21. Immunomodulatory functions of surfactant
22. Urinary cotinine as a tobacco-smoke exposure index: A minireview
23. Cotinine concentrations in amniotic fluid and urine of smoking, passive smoking and non-smoking pregnant women at term and in the urine of their neonates on 1st day of life
24. The retinol-binding protein
25. Diagnostic value of analysis of cystatin C and protein HC in biological fluids
26. Proteinuria: Changes and mechanisms in toxic nephropathies
27. Tubular proteins and enzyme content in the amniotic fluid
28. Low molecular mass proteins and urinary enzymes in amniotic fluid of healthy pregnant women at progressive stages of gestation
29. Microproteins in amniotic fluid as an index of changes in fetal renal function during development
30. Protein analysis in amniotic fluid and fetal urine for the assessment of fetal renal function and dysfunction
31. Association of intrauterine cigarette smoke exposure with indices of fetal lung maturation
32. Determinants of Clara cell protein CC16 concentration in serum: A reassessment with two different immunoassays
33. Clara cell protein in serum and bronchoalveolar lavage
34. Composition of human pulmonary surfactant varies with exercise and level of fitness
35. Continuous-flow system for automation of latex immunoassay by particle counting
36. Comparison of turbidimetry with particte counting for the determination of human beta 2-microglobulin by latex immunoassay LIA
37. Conjugated glucocorticoids in amniotic fluid and fetal lung maturation
38. Determination of nicotine and its main metabolites in urine by high-performance liquid chromatography
39. Human bronchoalveolar lavage fluid protein two-dimensional database: Study of interstitial lung diseases
40. The current state of two-dimensional electrophoresis with immobilized pH gradients
41. Solubilization of proteins for electrophoretic analyses
42. Two-dimensional electrophoretic patterns of acute-phase human serum proteins in the course of bacterial and viral diseases
43. Human bronchoalveolar lavage fluid: Two-dimensional gel electrophoresis, amino acid microsequencing and identification of major proteins
44. Early decrease of serum Clara cell protein in silica-exposed workers
45. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung
46. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers
47. Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients
48. Clara cell protein CC-16 and surfactant-associated protein A SP-A in asbestos-exposed workers
49. A two-dimensional protein map of human amniotic fluid at 17 weeks' gestation
50. Nicotine attenuates the ventilatory response to hypoxia in the developing lamb